Plain-English translation of NCT05305118 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called transcutaneous spinal cord stimulation (TSCS) to help stabilize blood pressure in people who have recently suffered a spinal cord injury. Low blood pressure is a common problem during recovery from spinal cord injury and can make it harder to participate in rehabilitation therapy. Researchers want to see if this non-invasive stimulation technique is safe, practical, and effective at keeping blood pressure stable.
After a spinal cord injury, many patients develop unstable or dangerously low blood pressure, which limits their ability to participate fully in rehabilitation. Current medications and treatments don't work well enough for everyone, so doctors need safer and more effective options.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive transcutaneous spinal cord stimulation during your hospital stay while undergoing acute rehabilitation for your spinal cord injury. The treatment involves placing electrodes on your skin over the spinal cord area (no surgery required) and activating them for short periods. The research team will work with you to find the best settings for your individual needs and will monitor your blood pressure response and overall safety throughout your participation.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
United States